fluconazole has been researched along with Acute Generalised Exanthematous Pustulosis in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saliba, E | 1 |
| Chrabieh, R | 1 |
| Tannous, Z | 1 |
| Jakkidi, M | 1 |
| Basmadjian, C | 1 |
| Roy, S | 1 |
2 other studies available for fluconazole and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Fluconazole-induced acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Antifungal Agents; Child; Fluconazole; Humans; Male | 2021 |
An illusion of septic shock: acute generalised exanthematous pustulosis with multiorgan dysfunction.
Topics: Acute Disease; Acute Generalized Exanthematous Pustulosis; Anti-Bacterial Agents; Anti-Inflammatory | 2017 |